Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients

BACKGROUND: Glioma is a deadly and immunosuppressive brain tumour. Complement C1r subcomponent like (C1RL), a prognostic biomarker in several kinds of tumours, has attracted increasing attention from oncologists. However, the role of C1RL in glioma remains unclear. METHODS: Through analysis of 2120...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Junyou, Tong, Luqing, Lin, Gaojun, Wang, Hui, Zhang, Liang, Yang, Xuejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526369/
https://www.ncbi.nlm.nih.gov/pubmed/32993564
http://dx.doi.org/10.1186/s12885-020-07436-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526369/
https://www.ncbi.nlm.nih.gov/pubmed/32993564
http://dx.doi.org/10.1186/s12885-020-07436-6

Ejemplares similares